{"url":"https://lda.senate.gov/api/v1/filings/de4292cb-2104-4e2d-a3f5-58ee134131c3/","filing_uuid":"de4292cb-2104-4e2d-a3f5-58ee134131c3","filing_type":"3A","filing_type_display":"3rd Quarter - Amendment","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/de4292cb-2104-4e2d-a3f5-58ee134131c3/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Katherine Landes","dt_posted":"2024-10-22T12:42:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"123 Highland Ave","registrant_address_2":"Suite 201","registrant_different_address":false,"registrant_city":"Needham","registrant_state":"MA","registrant_zip":"02494","registrant":{"id":401108711,"url":"https://lda.senate.gov/api/v1/registrants/401108711/","house_registrant_id":56565,"name":"STEALTH BIOTHERAPEUTICS INC.","description":null,"address_1":"123 Highland Ave","address_2":"Suite 201","address_3":null,"address_4":null,"city":"Needham","state":"MA","state_display":"Massachusetts","zip":"02494","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JUSTIN PHILLIPS","contact_telephone":"+1 202-543-8345","dt_updated":"2026-07-27T12:26:37.018027-04:00"},"client":{"id":61599,"url":"https://lda.senate.gov/api/v1/clients/61599/","client_id":61599,"name":"STEALTH BIOTHERAPEUTICS INC.","general_description":"Developing therapies to treat mitochondrial dysfunction.","client_government_entity":null,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-22"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 7384/S. 4583, the Creating Hope Reauthorization Act of 2024 H.R. 4758/S. 2372, the Accelerating Kids Access to Care Act H.R. 3433, the Give Kids A Chance Act General discussions about ultra-rare disease drug development General discussions about regulatory reform, including scientific-focused drug development meetings H.R. 1092/S. 526, the BENEFIT Act General discussions about mitochondrial diseases","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148675,"prefix":"ms","prefix_display":"MS.","first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"LANDES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}